BelHealth Investment Partners’ Linden Care appoints exec VP

Linden Care, a provider of specialty pharmacy services to the pain management industry, has added Anthony D. Luna as executive vice president of sales. Linden Care is a portfolio company of BelHealth Investment Partners.

PRESS RELEASE

Linden Care LLC (“Linden Care” or the “Company”), a leading provider of specialty pharmacy services to the pain management industry, announced the addition of Anthony D. Luna as Executive VP of Sales.
Mr. Luna brings more than 22 years of experience in the healthcare industry, with over 20 of those years being in specialty pharmacy. Prior to joining Linden Care, Mr. Luna was at Allion Healthcare, where he held many positions, most recently as both an officer of Allion Healthcare and the President of MOMs Pharmacy. Prior to joining Allion, Mr. Luna worked at Modern Healthcare Inc., and various other specialty and healthcare companies.
Linden Care has distinguished itself by providing robust and differentiated compliance practices as well as a full suite of “specialty” services to meet the needs of patients, physicians and pharmaceutical manufacturers in the pain management sector. The Company has built a stellar team and continues to expand its successful strategy toward becoming the national center of excellence for pain management.
Marc Wiener, CEO of Linden Care said, “Tony’s extensive experience and strong track record in building sales teams and selling strategies in the specialty pharmacy industry will help Linden Care expand its national footprint. We are pleased to add high-caliber individuals like Tony during this period of explosive growth”.
Anthony Luna said, “I am thrilled to join such a dynamic and growing company. This is a very exciting time for the company and Linden Care’s focus on service and compliance is exactly what the pain management industry needs and I look forward to developing Linden Care into a national brand”.
About Linden Care
Linden Care, headquartered in Syosset, NY, is a leading provider of specialty pharmacy services to the pain management industry. The Company offers comprehensive and highly personalized specialty pharmacy services targeting multiple growth markets through a unique “concierge pharmacy” business model. Since inception, the Company has distinguished itself by providing robust and differentiated compliance practices as well as a full suite of “specialty” services to meet the needs of patients, physicians and pharmaceutical manufacturers. The Company will continue to expand this successful strategy, currently focused on the Northeast, throughout the rest of the country, becoming the national center of excellence for pain management.
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth acquires majority positions in entrepreneur-owned companies we believe would benefit from our vast operating and private equity experience. The firm typically invests $10-25 million per platform company across four healthcare segments: Services, Products, Distribution and Technology. Applying an active, hands-on approach, BelHealth utilizes its experience to support management to drive revenue, profit growth and achieve superior returns for our investors and partners.

Related Posts

Leave a Reply

PEHUB Community

Join the 12503 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget